October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...

CureWise, the AI-powered platform Steve originally developed to help with his own rare blood cancer diagnosis, has evolved ...

Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has contributed to CURE as a blogger ...

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

The subsequent treatment involved intensive procedures, including five rounds of chemotherapy, external beam radiation, and ...

Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions.

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and ...